Cargando…
Transperineal intraprostatic injection of botulinum neurotoxin A vs transurethral resection of prostate for management of lower urinary tract symptoms secondary to benign prostate hyperplasia: A prospective randomised study
Objectives: To evaluate transperineal intraprostatic injection of botulinum neurotoxin A (BoNT-A) in patients with lower urinary tract symptoms (LUTS) secondary to benign prostate hyperplasia (BPH) who failed to respond to 6-month medical treatment compared with transurethral resection of the prosta...
Autores principales: | El-Dakhakhny, Amr S., Gharib, Tarek, Issam, Ahmed, El-Karamany, Tarek M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6830273/ https://www.ncbi.nlm.nih.gov/pubmed/31723444 http://dx.doi.org/10.1080/2090598X.2019.1662214 |
Ejemplares similares
-
Shared Inherited Genetics of Benign Prostatic Hyperplasia and Prostate Cancer
por: Glaser, Alexander, et al.
Publicado: (2022) -
The role of Rezum in the management of refractory urinary retention due to benign prostate hyperplasia: A literature review
por: Khalil, Ibrahim A., et al.
Publicado: (2023) -
Oral desmopressin in nocturia with benign prostatic hyperplasia: A systematic review of the literature
por: Taha, Diaa-Eldin, et al.
Publicado: (2018) -
Simultaneous antegrade and retrograde endoscopic surgery for benign prostatic hyperplasia with vesical calculi – A single-centre experience
por: Javali, Tarun, et al.
Publicado: (2018) -
WATER versus WATER II 2-Year Update: Comparing Aquablation Therapy for Benign Prostatic Hyperplasia in 30–80-cm(3) and 80–150-cm(3) Prostates
por: Nguyen, David-Dan, et al.
Publicado: (2021)